Clinical Trial Update: Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 multicenter randomized double-blind trial evaluated whether adding methotrexate improves and maintains response to anti-TNF therapy in adults with mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Certolizumab pegol (certolizumab pegol)
• Etanercept (etanercept)
• Infliximab (infliximab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Psoriasis | Phase 4 | Status: TERMINATED